EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Optimizing SARS-CoV-2 vaccine responses in kidney transplant recipients: an urgent need

Yi-Ling Cheng, Shen-Shin Chang, Chiao-Hsuan Chao, Po-Ta Chen, Ya-Lan Lin, Guan-Da Syu, Nan-Yao Lee, Po-Lin Chen iD, Wen-Chien Ko, Tzong-Shiann Ho iD

Microbiology Spectrum · 2024

DOI: 10.1128/spectrum.00004-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Yi-Ling Cheng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan. Hauptthemen laut MEDLINE: COVID-19 Vaccines, Kidney Transplantation, COVID-19, SARS-CoV-2. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council (NSTC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kidney transplant recipients (KTRs) have been identified as a population at increased risk for severe SARS-CoV-2 infection outcomes. This study focused on understanding the immune response of KTRs post-vaccination, specifically examining both serological and cellular responses to the SARS-CoV-2 vaccine. Thirteen individuals, including seven KTRs and six healthy donors, were evaluated for antibody levels and T cell responses post-vaccination. The study revealed that KTRs had significantly lower serological responses, including reduced anti-receptor binding domain (RBD) binding antibodies and neutralizing antibodies against the Wuhan, Delta, and Omicron BA.2 strains. Additionally, KTRs demonstrated weaker CD8 T cell cytotoxic responses and lower Th1 cytokine secretion, particularly IFN-γ, after stimulation with variant spike peptide pools. These findings highlight the compromised immunity in KTRs post-vaccination and underscore the need for tailored strategies to bolster immune responses in this vulnerable group. Further investigations are warranted into the mechanisms underlying reduced vaccine efficacy in KTRs and potential therapeutic interventions. IMPORTANCE Some studies have revealed that KTRs had lower serological response against SARS-CoV-2 than healthy people. Nevertheless, limited studies investigate the cellular response against SARS-CoV-2 in KTRs receiving SARS-CoV-2 vaccines. Here, we found that KTRs have lower serological and cellular responses. Moreover, we found that KTRs had a significantly lower IFN-γ secretion than healthy individuals when their PBMCs were stimulated with SARS-CoV-2 spike peptide pools. Thus, our findings suggested that additional strategies are needed to enhance KTR immunity triggered by the vaccine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 VaccinesKidney TransplantationCOVID-19SARS-CoV-2Transplant RecipientsAntibodies, ViralAntibodies, NeutralizingHumansMiddle AgedMaleFemaleAdultSpike Glycoprotein, CoronavirusAgedCD8-Positive T-LymphocytesVaccinationInterferon-gamma

Stichwörter der Autor:innen

COVID-19SARS-CoV-2T cell responsecytokineskidney transplanted recipientserological responsevaccinationvariant spike peptide pools

Substanzen

COVID-19 VaccinesAntibodies, ViralAntibodies, NeutralizingSpike Glycoprotein, CoronavirusInterferon-gamma

Autor:innen und Institutionen

  • Department of Pediatrics, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Department of Medical Laboratory and Regenerative Medicine, MacKay Medical College, New Taipei, Taiwan.
  • Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Department of Biotechnology and Bioindustry Sciences, National Cheng Kung University, Tainan, Taiwan.
  • Medical Device Innovation Center, National Cheng Kung University, Tainan, Taiwan.

ORCID-Profile: Po-Lin Chen, Tzong-Shiann Ho

Förderung

  • National Science and Technology Council (NSTC)

Zitieren

APA

Cheng, Y. L., Chang, S. S., Chao, C. H., Chen, P. T., Lin, Y. L., Syu, G. D., Lee, N. Y., Chen, P. L., Ko, W. C., & Ho, T. S. (2024). Optimizing SARS-CoV-2 vaccine responses in kidney transplant recipients: an urgent need. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00004-24

Vancouver

Cheng YL, Chang SS, Chao CH, Chen PT, Lin YL, Syu GD, et al. Optimizing SARS-CoV-2 vaccine responses in kidney transplant recipients: an urgent need. Microbiology Spectrum. 2024. doi:10.1128/spectrum.00004-24

BibTeX
@article{Cheng2024,
  author = {Cheng, Yi-Ling and Chang, Shen-Shin and Chao, Chiao-Hsuan and Chen, Po-Ta and Lin, Ya-Lan and Syu, Guan-Da and Lee, Nan-Yao and Chen, Po-Lin and Ko, Wen-Chien and Ho, Tzong-Shiann},
  title = {Optimizing SARS-CoV-2 vaccine responses in kidney transplant recipients: an urgent need},
  journal = {Microbiology Spectrum},
  year = {2024},
  doi = {10.1128/spectrum.00004-24}
}
Kostenlos starten →